Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01385449 · ClinicalTrials.gov registry record · NA
Prospective Evaluation of Interscalene Nerve Catheters vs. Single Injection Blocks
A NA study, sponsored by University of Wisconsin, Madison.
- Terminated
- Registry status
- NA
- Development phase
- 73
- Enrollment target
NCT01385449: Clinical Trial NA study, sponsored by University of Wisconsin, Madison.
NCT01385449 is a NA study that was terminated before completion, run by University of Wisconsin, Madison. The registered enrollment target is 73 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01385449, a NA study, was terminated before completion, sponsored by University of Wisconsin, Madison.
- TERMINATED
- Registry status
- NA
- Development phase
- 73 participants
- Enrollment target
Study Summary
The primary hypothesis is that those patients who choose an interscalene catheter will have less pain postoperatively than those with single injection blocks. Secondary hypotheses examine physical therapy outcomes and incidence of parasthesia or pain following surgery for up to 3 months.
Primary Outcome
Pain score on post-operative day 1(POD1) using numeric rating scale (NRS)
Interventions
- PROCEDURE interscalene catheter
- PROCEDURE interscalene block
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 73 participants |
| Start Date | 2011-06 |
| Est. Completion | 2016-02 |
| Phase | NA |
Why NCT01385449 stopped before completion
NCT01385449 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 73 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).
The record links to 0 conditions, and to 2 interventions - of which interscalene catheter is the first listed.
NCT01385449 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01385449 about?
NCT01385449 is a clinical study titled "Prospective Evaluation of Interscalene Nerve Catheters vs. Single Injection Blocks". The primary hypothesis is that those patients who choose an interscalene catheter will have less pain postoperatively than those with single injection blocks. Secondary hypotheses examine physical therapy outcomes and incidence of parasthesia or pain following surgery for up to 3 months.
What is the current status of trial NCT01385449?
This trial is currently terminated. It is a NA study. The enrollment target is 73 participants. The study started on 2011-06. Estimated completion is 2016-02.
What interventions are being tested in trial NCT01385449?
The interventions under investigation include: interscalene catheter (PROCEDURE), interscalene block (PROCEDURE).
Who is sponsoring clinical trial NCT01385449?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01385449's enrollment target sits among peer trials
73 1089th of 2000 higher than 912 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03661307 · 73 participants · Phase 1
Quizartinib, Decitabine, and Venetoclax in Treating Participants With Untreated or Relapsed Acute Myeloid Leukemia or High Risk Myelodysplastic Syndrome
- NCT05386108 · 73 participants · Phase 1
Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast Cancer
- NCT05961592 · 73 participants · Phase 1
R-2487 in Patients With Rheumatoid Arthritis
- NCT06150664 · 73 participants · Phase 1
A Phase 1 of CTX-8371 in Patients With Advanced Malignancies
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia